ARA Current Clinical Trials

OraQuick Assay

A study testing the effectiveness of a new 20-minute oral HIV-test.

Background	OraSure has previously developed an effective oral HIV test. Results currently require a one-to-two week turnaround.
Objective	To determine whether the new OraQuick oral assay is a reliable means of ascertaining HIV status. This assay would reduce the current HIV-test turnaround time to 20 minutes, helping to ensure that those tested are not lost to follow-up.
Study Design	Volunteers will be assigned to one of two study groups: Group 1: HIV-positive volunteers. Each volunteer will have an oral swab, finger prick blood test and standard blood draw taken. Group 2: HIV-negative volunteers. Each volunteer will have an oral swab, finger prick blood test and standard blood draw taken.
Inclusion Criteria	Two kinds of volunteers are needed: Volunteers who are HIV-positive and Volunteers who are HIV-negative
Status __	Enrolling --
Volunteers will receive $30 compensation for their inconvenience. For more information about participating in this study in the Los Angeles area, please call 310/358.2429 or e-mail Corie Castro at ccastro@aidsresearch.org
We encourage participation by women and people of color. This ad was reviewed and approved by the AIDS Research Alliance Institutional Review Board in December, 2000.